LCT stock up 20% after Japan deal
12 April, 2011 by Staff WritersLiving Cell Technologies (ASX:LCT) has entered into an agreement with Japanese biopharma company, Otsuka Pharmaceutical Factory worth $3 million.
Sirtex sees sales of SIR-Spheres ascend
11 April, 2011 by Staff WritersSirtex (ASX:SRX) shares are up 2.5% after the company reported a 21% increase in dose sales of its liver cancer treatment, SIR-Spheres.
Qiagen makes a grab for Cellestis
04 April, 2011 by Tim DeanCellestis board gives tick of approval to the deal which values the tuberculosis diagnostic company at $341.3 million.
Feature: Shortening the odds in drug design
01 April, 2011 by Fiona WylieFinding just the ideal molecule with just the right binding properties from countless contenders is a daunting challenge for drug design.
Feature: Making drug resistance futile
01 April, 2011 by Fiona WylieMartin Scanlon and his team are using the new fragment-based drug design to combat drug resistance.
Positive trial results for anti-anxiety drug give Bionomics a stock bump
30 March, 2011 by Staff WritersPositive Phase Ib clinical trials of Bionomics’ (ASX:BNO) anti-anxiety drug, BNC210, has seen the stock jump by over 10%.
ChemGenex to be acquired by Cephalon
29 March, 2011 by Tim DeanThe share price of Australian biopharma, ChemGenex (ASX:CXS), has soared following news that US-based Cephalon is making a bid to purchase the company.
Australia signs up to compulsory licensing of drugs for developing countries in need
25 March, 2011 by Tim DeanThe Australian Government has announced it will allow compulsory licensing of pharmaceuticals for export to developing countries in crisis under the WTO TRIPS Protocol.
Co-opting nature to make cheaper drugs
21 March, 2011 by Tim DeanAustralian scientists have developed a method for producing drugs that could combat cancer and other diseases by co-opting the natural machinery of sunflowers.
Glycomics could eliminate food poisoning from chicken
16 March, 2011 by Staff WritersA food additive for chickens developed using gylcomics could virtually eliminate the risk of getting food poisoning from raw chicken meat.
Clinuvel to begin trial of Scenesse in US and Europe
04 March, 2011 by Staff WritersPilot trials of Clinuvel’s skin repigmentation treatment, Scenesse (afamelanotide), will begin in the US and Europe to treat vitiligo.
Immuron granted patent for anti-influenza product
02 March, 2011 by Staff WritersAustralian patent issued for Imm-255, which is an orally administered anti-influenza candidate.
Bioscience boost at La Trobe
28 February, 2011 by Tim DeanThe $94 million La Trobe Institute of Molecular Science began construction last week and is set to open in 2012.
Living Cell Technologies and HealthLinx receive key patents
24 February, 2011 by Tim DeanLiving Cell Technologies (ASX:LCT) has received an Australian patent for its encapsulation technology, while HealthLinx (ASX:HTX) had its OvPlex diagnostic technology patented in the UK.
Sirtex posts strong 1H results
23 February, 2011 by Staff WritersSirtex Medical (ASX:SRX) posts $3.6 million profit on the back of increased sales in the face of currency bump.
